Clinical trial
Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever
NCT00310466 · ALK-Abelló A/S, Industry · Completed
Key facts
| NCT number | NCT00310466 |
|---|---|
| Title | Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever |
| Official title | A Multicentre, Randomised, Double-blind, Placebo-controlled Parallel Group Clinical Trial to Investigate the Efficacy and Safety of Specific Sublingual Immunotherapy With SLITone Birch in Patients With Seasonal Birch Pollen Induced Rhinoconjunctivitis |
| Lead sponsor | ALK-Abelló A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allergy |
| Intervention type | Biological |
| Interventions | Sublingual immunotherapy, Placebo |
| Enrollment | 226 |
| Start date | Jun 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Apr 4, 2006 |
| Last update posted | May 14, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: